Abstract:With the continuous development of imaging technology and nanotechnology, it is expected to further make in‐depth study on tumor‐associated bacteria and develop new bacterial imaging methods for tumor diagnosis. Some bacteria, such as Escherichia coli (E. coli) and Salmonella typhimurium (S. typhimurium), have an inherent ability to locate solid tumours, making them a versatile platform that can be combined with other tools to improve the tumour diagnosis and treatment. In anti‐cancer therapy, bacteria function by carrying drugs directly or expressing exogenous therapeutic genes. The application of bacterial imaging in tumour diagnosis, a novel and promising research area, can indeed provide dynamic and real‐time monitoring in both pre‐treatment assessment and post‐treatment detection. Different imaging techniques, including optical technology, acoustic imaging, magnetic resonance imaging (MRI) and nuclear medicine imaging, allow us to observe and track tumour‐associated bacteria. Optical imaging, including bioluminescence and fluorescence, provides high‐sensitivity and high‐resolution imaging. Acoustic imaging is a real‐time and non‐invasive imaging technique with good penetration depth and spatial resolution. MRI provides high spatial resolution and radiation‐free imaging. Nuclear medicine imaging, including positron emission tomography (PET) and single photon emission computed tomography (SPECT) can provide information on the distribution and dynamics of bacterial population. Moreover, strategies of synthetic biology modification and nanomaterial engineering modification can improve the viability and localization ability of bacteria while maintaining their autonomy and vitality, thus aiding the visualization of gut bacteria. However, there are some challenges, such as the relatively low bacterial abundance and heterogeneously distribution within the tumour, the high dimensionality of spatial datasets and the limitations of imaging labeling tools. In summary, with the continuous development of imaging technology and nanotechnology, it is expected to further make in‐depth study on tumour‐associated bacteria and develop new bacterial imaging methods for tumour diagnosis.

Research progress of contrast agents for bacterial infection imaging in vivo

Research Progress of Magnetic Resonance Imaging Contrast Agents

Carbon dots: Current advances in pathogenic bacteria monitoring and prospect applications

Research progress in bio-responsive MRI contrast agent

Carbon Dots: Current Advances in Pathogenic Bacteria Monitoring and Prospect Applications.

Recently developed radiopharmaceuticals for bacterial infection imaging

Bacterial imaging in tumour diagnosis

The Application of Inorganic Optical Nanoprobes in Bacterial Infection

Bacteria‐Based Living Probes: Preparation and the Applications in Bioimaging and Diagnosis

Advances in Image-Guided Drug Delivery for Antibacterial Therapy

Small Molecular Fluorescent Probes: Application Progress of Specific Bacteria Detection and Antibacterial Phototherapy

Recent advances of fluorescent sensors for bacteria detection-A review

Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance

Maltodextrin-based Imaging Probes Detect Bacteria in Vivo with High Sensitivity and Specificity

Progress and challenges in bacterial infection theranostics based on functional metal nanoparticles

Highlights of the Latest Developments in Radiopharmaceuticals for Infection Imaging and Future Perspectives

Advances in the Development of Bacterial Bioluminescence Imaging

Emerging Contrast Agents for Multispectral Optoacoustic Imaging and Their Biomedical Applications

Quantum Dots for Pathogenic Bacterial Monitoring and Combating

Near-infrared chemiluminescent nanoprobes for deep imaging and synergistic photothermal-nitric-oxide therapy of bacterial infection

Nonconventional Imaging for Viable Bacteria Detection: A Review